Angiodynamics (ANGO) FCF Margin (2010 - 2026)
Angiodynamics' (ANGO) quarterly FCF Margin came in at 20.07% in Q2 2026, down 265.0% on a YoY basis from 12.16% in Q2 2025, and up 536.96% quarter-over-quarter from 4.59% in Q1 2026.
Powered by 
Analysis
Angiodynamics (ANGO) FCF Margin (2010 - 2026) Analysis & Trends
Angiodynamics (ANGO) has reported FCF Margin for 17 consecutive years, with 20.07% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, FCF Margin fell 265.0% year-over-year to 20.07%; the trailing twelve-month figure through May 2026 stood at 0.16% (up 515.0% YoY), and the FY2026 full-year result was 0.16%, up 515.0% from the prior year.
- FCF Margin rose to 20.07% in Q2 2026 per ANGO's latest filing, from 4.59% in the prior quarter.
- Across five years, FCF Margin topped out at 22.72% in Q2 2025 and bottomed at 33.92% in Q3 2023.
- Historically, FCF Margin has averaged 4.01% across 5 years, with a median of 0.83% in 2023.
- The sharpest annual moves came in 2022 and 2026: FCF Margin slumped 2020 bps in 2022, then jumped 1561 bps in 2026.
- Over 5 years, FCF Margin stood at 7.36% in 2022, then plunged by 30 bps to 5.12% in 2023, then sank by 65 bps to 1.8% in 2024, then jumped by 143 bps to 4.36% in 2025, then surged by 360 bps to 20.07% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 20.07%, 4.59%, and 4.36% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 15.81% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 32.79% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 13.22% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 16.07% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 23.50% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 33.60% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 21.78% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 14.10% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 18.73% |
| 10 | Angiodynamics | 633.27 Mn | 579.41 Mn | 46.77 Mn | 20.07% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 20.07% |
| Feb 28, 2026 | -4.59% |
| Nov 30, 2025 | 4.36% |
| Aug 31, 2025 | -22.10% |
| May 31, 2025 | 22.72% |
| Feb 28, 2025 | -20.21% |
| Nov 30, 2024 | 1.80% |
| Aug 31, 2024 | -28.99% |
| May 31, 2024 | 8.07% |
| Feb 29, 2024 | -18.31% |
| Nov 30, 2023 | 5.12% |
| Aug 31, 2023 | -33.92% |
| May 31, 2023 | 18.74% |
| Feb 28, 2023 | -0.14% |
| Nov 30, 2022 | 7.36% |
| Aug 31, 2022 | -33.08% |
| May 31, 2022 | 14.87% |
| Feb 28, 2022 | -13.89% |
| Nov 30, 2021 | -0.99% |
| Aug 31, 2021 | -17.38% |